Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients.

Trial Profile

Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Nov 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Docetaxel; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms SELECT-BC
  • Most Recent Events

    • 02 Nov 2016 Results (n=380) analysing impacts of adverse events on health-related quality of life in patients from SELECT BC study, presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
    • 23 Nov 2015 Results published in the Lancet Oncology
    • 02 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top